Header Logo

Connection

GARABED EKNOYAN to Kidney Failure, Chronic

Back to Details
This is a "connection" page, showing publications GARABED EKNOYAN has written about Kidney Failure, Chronic.
GARABED EKNOYAN
Connection Strength
3.322
Kidney Failure, Chronic
  1. A historical perspective of how public policy shaped dialysis care delivery in the United States. Semin Dial. 2020 01; 33(1):5-9.
    View in: PubMed
    Score: 0.394
  2. The kidney in sickle hemoglobinopathies?. Clin Nephrol. 2017 Feb; 87 (2017)(2):55-68.
    View in: PubMed
    Score: 0.321
  3. Artificial kidneys: progress and promise. Lancet. 2007 Dec 15; 370(9604):1977-8.
    View in: PubMed
    Score: 0.170
  4. Obesity, diabetes, and chronic kidney disease. Curr Diab Rep. 2007 Dec; 7(6):449-53.
    View in: PubMed
    Score: 0.170
  5. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb; 17(2):546-55.
    View in: PubMed
    Score: 0.149
  6. Introduction: Adequacy of dialysis: problems and challenges. Semin Nephrol. 2005 Mar; 25(2):67-9.
    View in: PubMed
    Score: 0.140
  7. Meeting the challenges of the new K/DOQI guidelines. Am J Kidney Dis. 2003 Jun; 41(5 Suppl):3-10.
    View in: PubMed
    Score: 0.124
  8. On the evolving nature of understanding dialysis-related disorders. Am J Kidney Dis. 2003 Apr; 41(4 Suppl 4):S1-3.
    View in: PubMed
    Score: 0.123
  9. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19; 347(25):2010-9.
    View in: PubMed
    Score: 0.121
  10. Impact of the new K/DOQI guidelines. Blood Purif. 2002; 20(1):103-8.
    View in: PubMed
    Score: 0.113
  11. The national epidemic of chronic kidney disease. What we know and what we can do. Postgrad Med. 2001 Sep; 110(3):23-9: quiz 8.
    View in: PubMed
    Score: 0.110
  12. NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease. Nephrol News Issues. 2001 Jul; 15(8):13, 54.
    View in: PubMed
    Score: 0.109
  13. Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 2001 Jan; 37(1):179-194.
    View in: PubMed
    Score: 0.105
  14. NKF-K/DOQI Clinical Practice Guidelines: Update 2000. Foreword. Am J Kidney Dis. 2001 Jan; 37(1 Suppl 1):S5-6.
    View in: PubMed
    Score: 0.105
  15. Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials. 2000 Oct; 21(5):502-25.
    View in: PubMed
    Score: 0.103
  16. On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes. Am J Kidney Dis. 1998 Nov; 32(5 Suppl 3):S1-4.
    View in: PubMed
    Score: 0.091
  17. Does the choice of renal replacement therapy adversely affect the hypercoagulability associated with renal disease? Am J Nephrol. 1998; 18(3):175-8.
    View in: PubMed
    Score: 0.085
  18. ?-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study. Am J Kidney Dis. 2011 Dec; 58(6):939-45.
    View in: PubMed
    Score: 0.055
  19. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011 Nov; 80(10):1080-91.
    View in: PubMed
    Score: 0.055
  20. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010 Apr; 77(7):624-9.
    View in: PubMed
    Score: 0.049
  21. The wonderful apparatus of John Jacob Abel called the "artificial kidney". Semin Dial. 2009 May-Jun; 22(3):287-96.
    View in: PubMed
    Score: 0.047
  22. Progress and promise in the management of chronic kidney disease. CMAJ. 2008 Nov 18; 179(11):1107-8.
    View in: PubMed
    Score: 0.045
  23. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Jan; 3(1):69-77.
    View in: PubMed
    Score: 0.043
  24. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80.
    View in: PubMed
    Score: 0.042
  25. Chronic renal failure. The primary care physician's role. Postgrad Med. 1986 May 01; 79(6):221-6, 228-30.
    View in: PubMed
    Score: 0.038
  26. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv Chronic Kidney Dis. 2005 Apr; 12(2):223-9.
    View in: PubMed
    Score: 0.035
  27. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004 Nov; 44(5 Suppl 2):1-6.
    View in: PubMed
    Score: 0.034
  28. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int. 2004 Apr; 65(4):1386-94.
    View in: PubMed
    Score: 0.033
  29. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003 Jun; 111(6 Pt 1):1416-21.
    View in: PubMed
    Score: 0.031
  30. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. Am J Kidney Dis. 2003 Apr; 41(4):868-76.
    View in: PubMed
    Score: 0.031
  31. Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol. 2002 Sep; 13(9):2345-52.
    View in: PubMed
    Score: 0.030
  32. Augmented polymorphonuclear chemiluminescence in patients with secondary hyperparathyroidism. J Lab Clin Med. 1981 Feb; 97(2):291-8.
    View in: PubMed
    Score: 0.026
  33. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol. 1981; 1(1):17-23.
    View in: PubMed
    Score: 0.026
  34. Methods used to evaluate the quality of evidence underlying the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: description, findings, and implications. Am J Kidney Dis. 2000 Jul; 36(1):1-11.
    View in: PubMed
    Score: 0.025
  35. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998 Nov; 32(5):853-906.
    View in: PubMed
    Score: 0.023
  36. Minocycline and doxycycline kinetics in chronic renal failure. Clin Pharmacol Ther. 1978 Aug; 24(2):233-9.
    View in: PubMed
    Score: 0.022
  37. Malignant hypertension. Recovery of kidney function after renal allograft failure. Arch Intern Med. 1975 Feb; 135(2):300-3.
    View in: PubMed
    Score: 0.017
  38. Platelet function in renal failure. N Engl J Med. 1969 Mar 27; 280(13):677-81.
    View in: PubMed
    Score: 0.012
  39. The natural history of primary pyelonephritis. Contrib Nephrol. 1989; 75:82-9.
    View in: PubMed
    Score: 0.011
  40. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007 Jan; 14(1):3-12.
    View in: PubMed
    Score: 0.010
  41. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2006 Apr; 47(4):614-24.
    View in: PubMed
    Score: 0.009
  42. Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J Am Soc Nephrol. 2005 Nov; 16(11):3371-80.
    View in: PubMed
    Score: 0.009
  43. The HEMO Study: applicability and generalizability. Nephrol Dial Transplant. 2005 Feb; 20(2):278-84.
    View in: PubMed
    Score: 0.009
  44. Effects of renal failure on leukotaxis. J Med. 1979; 10(4):267-78.
    View in: PubMed
    Score: 0.006
  45. Human parotid saliva urea in renal failure and during dialysis. Arch Oral Biol. 1977; 22(2):83-6.
    View in: PubMed
    Score: 0.005
  46. Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med. 1975 Jun; 135(6):807-10.
    View in: PubMed
    Score: 0.004
  47. Peritoneal dialysis in the treatment of renal failure in multiple myeloma. South Med J. 1971 Nov; 64(11):1403-5.
    View in: PubMed
    Score: 0.003
  48. Adult polycystic kidney disease: studies of the defect in urine concentration. Kidney Int. 1972 Aug; 2(2):107-13.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.